Literature DB >> 24293287

The effects of shRNA-mediated gene silencing of transcription factor SNAI1 on the biological phenotypes of breast cancer cell line MCF-7.

Yan Lu1, Lina Yu, Minlan Yang, Xiangshu Jin, Zhijing Liu, Xiaowei Zhang, Liping Wang, Dongjing Lin, Yuanyuan Liu, Min Wang, Chengshi Quan.   

Abstract

To research the effects of silencing transcription factor SNAI1 on the in vitro biological phenotypes of breast cancer cell line MCF-7, based on the gene sequence of SNAI1, we linked shRNA with the green fluorescent protein-expressing eukaryotic expression vector pGCsilencer™ U6/Neo/GFP, and transfected it into MCF-7 cells. The SNAI1 gene-silencing effect was authenticated by RT-PCR and immunofluorescence. We then examined the effect of gene silencing on the expression of epithelial and mesenchymal markers and on their biological phenotypes of the target cells. Finally, we explained that SNAI1 was bound to E-cadherin in MCF-7 cells by ChIP. Silencing SNAI1 upregulated the expression of epithelial markers claudin-4, claudin-7, and E-cadherin, while expression of the mesenchymal marker matrix metalloproteinase-2 was downregulated. The capacity for proliferation, migration, and invasion was diminished. SNAI1 binds to the E-cadherin gene promoter and inhibits its transcription. We can conclude that silencing gene SNAI1 inhibits expression of properties that are associated with the malignant phenotype of MCF-7 cells and reverses the epithelial-mesenchymal transition process by regulating relevant target gene E-cadherin.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24293287     DOI: 10.1007/s11010-013-1903-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  39 in total

1.  Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail.

Authors:  Junichi Ikenouchi; Miho Matsuda; Mikio Furuse; Shoichiro Tsukita
Journal:  J Cell Sci       Date:  2003-03-26       Impact factor: 5.285

Review 2.  EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.

Authors:  A Singh; J Settleman
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

Review 3.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

4.  Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression.

Authors:  Loredana Mauro; Stefania Catalano; Gianluca Bossi; Michele Pellegrino; Ines Barone; Sara Morales; Cinzia Giordano; Viviana Bartella; Ivan Casaburi; Sebastiano Andò
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

5.  Prohibitin is a novel target gene of vitamin D involved in its antiproliferative action in breast cancer cells.

Authors:  Xinjian Peng; Rajeshwari Mehta; Sheng Wang; Srikumar Chellappan; Rajendra G Mehta
Journal:  Cancer Res       Date:  2006-07-15       Impact factor: 12.701

Review 6.  Key signalling nodes in mammary gland development and cancer. The Snail1-Twist1 conspiracy in malignant breast cancer progression.

Authors:  Ellen Foubert; Bram De Craene; Geert Berx
Journal:  Breast Cancer Res       Date:  2010-06-25       Impact factor: 6.466

Review 7.  Epithelial-mesenchymal transition in development and cancer.

Authors:  Douglas S Micalizzi; Heide L Ford
Journal:  Future Oncol       Date:  2009-10       Impact factor: 3.404

8.  Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010.

Authors:  Kyu-Won Jung; Young-Joo Won; Hyun-Joo Kong; Chang-Mo Oh; Hong Gwan Seo; Jin-Soo Lee
Journal:  Cancer Res Treat       Date:  2013-03-31       Impact factor: 4.679

9.  PAI-1 and functional blockade of SNAI1 in breast cancer cell migration.

Authors:  Elizabeth Fabre-Guillevin; Michel Malo; Amandine Cartier-Michaud; Hector Peinado; Gema Moreno-Bueno; Benoît Vallée; Daniel A Lawrence; José Palacios; Amparo Cano; Georgia Barlovatz-Meimon; Cécile Charrière-Bertrand
Journal:  Breast Cancer Res       Date:  2008-12-03       Impact factor: 6.466

10.  E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1).

Authors:  B St Croix; C Sheehan; J W Rak; V A Flørenes; J M Slingerland; R S Kerbel
Journal:  J Cell Biol       Date:  1998-07-27       Impact factor: 10.539

View more
  5 in total

Review 1.  Exosomes and cancer: from molecular mechanisms to clinical applications.

Authors:  Ameneh Jafari; Amirhesam Babajani; Meghdad Abdollahpour-Alitappeh; Nayebali Ahmadi; Mostafa Rezaei-Tavirani
Journal:  Med Oncol       Date:  2021-03-20       Impact factor: 3.064

2.  TGF-β1 alters esophageal epithelial barrier function by attenuation of claudin-7 in eosinophilic esophagitis.

Authors:  N Nguyen; S D Fernando; K A Biette; J A Hammer; K E Capocelli; D A Kitzenberg; L E Glover; S P Colgan; G T Furuta; J C Masterson
Journal:  Mucosal Immunol       Date:  2017-08-23       Impact factor: 7.313

3.  Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.

Authors:  Yifan Li; Yanqing Gong; Xianghui Ning; Ding Peng; Libo Liu; Shiming He; Kan Gong; Cuijian Zhang; Xuesong Li; Liqun Zhou
Journal:  J Exp Clin Cancer Res       Date:  2018-11-14

4.  SMAD2 Inactivation Inhibits CLDN6 Methylation to Suppress Migration and Invasion of Breast Cancer Cells.

Authors:  Yan Lu; Liping Wang; Hairi Li; Yanru Li; Yang Ruan; Dongjing Lin; Minlan Yang; Xiangshu Jin; Yantong Guo; Xiaoli Zhang; Chengshi Quan
Journal:  Int J Mol Sci       Date:  2017-08-30       Impact factor: 5.923

5.  Role of ANKHD1/LINC00346/ZNF655 Feedback Loop in Regulating the Glioma Angiogenesis via Staufen1-Mediated mRNA Decay.

Authors:  Chunqing Yang; Jian Zheng; Xiaobai Liu; Yixue Xue; Qianru He; Yiming Dong; Di Wang; Zhen Li; Libo Liu; Jun Ma; Heng Cai; Yunhui Liu
Journal:  Mol Ther Nucleic Acids       Date:  2020-05-12       Impact factor: 8.886

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.